Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets
LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a clinical-stage precision medicine company, today announced that its subsidiary BioSymetrics has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent application titled 'Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions' (Application No. 18/058,752).
This patent strengthens Renovaro's AI and machine learning intellectual property portfolio by protecting novel methods for integrating and harmonizing diverse biomedical data sources—such as genomics, electronic health records, imaging, and clinical trial data—into a standardized framework for predictive modeling.
'This patent is a strategic milestone for Renovaro,' said David Weinstein, CEO of Renovaro. 'Together with our previously granted patent, it forms the technological foundation of a scalable, end-to-end platform for AI-powered drug discovery and diagnostics and strengthens our position in the fast-growing market for data-driven therapeutics and clinical insights.'
Key Drivers for Renovaro:
Expands Foundational IP: Builds on core patent (US 11,379,757), granted in July 2022, which protects machine learning pipeline optimization through advanced feature selection and model tuning.
Addresses Real-World Challenges: Tackles integration of siloed and heterogeneous data—an unmet need in pharmaceutical R&D and clinical practice.
Enhances Commercial Potential: Enables scalable, distributed computing for biomedical analytics across use cases in rare disease, clinical trials, and personalized medicine.
Supports Revenue Growth Strategy: Protects Renovaro's differentiated technology approach, critical for commercial partnerships, licensing opportunities, and platform deployment in life sciences and healthcare.
The new patent introduces methods that operate across distributed and parallel computing environments, allowing for real-time, reproducible predictive analytics at scale. This infrastructure is vital as the biopharma industry increases reliance on AI to improve efficiency, reduce costs, and accelerate time-to-market for new therapies.
This patent allowance reinforces Renovaro's commitment to building category-defining technology platforms that drive value for patients, partners, and shareholders alike.
About Renovaro Inc.
Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development, and BioSymetrics which specializes in contingent AI for precision neurology. For more information, visit www.renovarogroup.com.
Forward-Looking Statements
This release contains forward-looking statements, including those relating to the pending litigation and the proposed merger. These statements involve risks and uncertainties and are subject to change based on future developments. Renovaro undertakes no obligation to update any forward-looking statements except as required by law.
Investor Relations
Chris Tyson
Executive Vice President
MZ Group - MZ North America
949-491-8235
RENB@mzgroup.us
www.mzgroup.us
For media inquiries, please contact:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
20 minutes ago
- Globe and Mail
Why Bank of America's (BAC) Bold Leap for Digital Dollars Could Benefit Shareholders
Legacy banks are beginning to embrace digital assets, and Bank of America (BAC) is the latest to prepare for a potential U.S. dollar-backed stablecoin, pending regulatory clarity. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The timing aligns with growing momentum behind the GENIUS Act (Guiding and Establishing National Innovation for U.S. Stablecoins) in Washington. As Bank of America signals caution about the macroeconomic outlook for the rest of 2025, this strategic move reflects both a necessary shift to keep pace with peers and a bold step into uncharted territory. While the risks are real and the implications far-reaching, I remain cautiously bullish about BAC's forward-looking approach. Joining Forces for a Unified Digital Dollar Network Bank of America is planning to join major peers, such as JPMorgan Chase (JPM), Wells Fargo (WFC), and Citigroup (C), in developing a stablecoin network modeled after Zelle. The initiative would leverage existing infrastructure—specifically, Early Warning Services and The Clearing House—to create a unified, fiat-backed stablecoin designed for retail and cross-border payments. The goal is to streamline traditional systems, such as ACH, by offering faster and more cost-efficient transactions. Bank of America has also floated the idea of launching its own 'Bank of America Coin', but for any of this to move forward, it will depend on the passage of favorable legislation. Washington Paves the Way with the GENIUS Act This is where the GENIUS Act comes into play. Just days ago, the Senate passed the crypto regulation bill with strong bipartisan support in a 68–30 vote, sending it to the House for further consideration. The bill includes key provisions like 1:1 reserve backing, segregated customer funds, and strict anti–money laundering standards. Regulation has always been an inevitable and necessary step for digital assets, and now that more explicit rules are emerging, traditional banks are finally feeling confident enough to get involved. Costs and Benefits for BAC Shareholders There are clear incentives for banks to enter the stablecoin market. It offers potential cost savings, new revenue streams from transaction processing, and opportunities to develop innovative financial products. At a broader level, it could help reinforce the U.S. dollar's dominance as the global reserve currency. However, stablecoins carry real risks. Though more 'stable' than unbacked cryptocurrencies, they are still vulnerable to collapse, as seen with TerraUSD in 2022, and pose potential systemic threats. Critics warn that the failure of a major issuer could have a ripple effect across the financial system. Some advocacy groups argue the GENIUS Act lacks sufficient consumer protections and could shift the burden of failure onto taxpayers. Building a Zelle-style stablecoin alliance also presents challenges. Banks must align on key features and governance—a challenging task given differing priorities. Even if the network succeeds, it will face competition from established players like Circle's USDC, Tether (USDT), and PayPal (PYUSD). Retail giants like Walmart and Amazon are also eyeing the space, potentially bypassing card networks like Visa by tapping into their massive customer bases. Bank of America's Strong Q1 Amidst Macroeconomic Caution Still, this transformation will take time to unfold. In the meantime, Bank of America's Q1 2025 earnings were largely positive. The bank posted a solid EPS beat at $0.90, driven by a 9% year-over-year rise in sales and trading revenue and 4% growth in consumer spending. Perhaps most notably, Bank of America's capital position is stronger than ever, with total assets climbing to $3.35 trillion. However, the outlook isn't as rosy as its first quarter results. The company expressed uncertainty over the macroeconomic outlook due to potential tariffs and their impact on the economy. For example, if retailers raise the price of a television due to tariffs, fewer Americans will use their Bank of America cards to process the transaction. So, banks are quite vulnerable to economic stagnation. This, combined with the risky pivot into digital currencies, may be 'cause for pause' among investors. Is Bank of America a Buy, Sell, or Hold? On Wall Street, BAC earns a Strong Buy consensus rating based on 18 Buy, two Hold, and zero Sell ratings in the past three months. BAC's average price target of $49.38 implies an upside potential of almost 10% over the next 12 months. Recently, Wells Fargo analyst Mike Mayo issued a Buy rating on BAC, noting the bank's 'strategic focus on expanding its consumer deposits and wealth management services, along with international commercial expansion, positions it for long-term growth.' BAC Positioned for a Win in Ongoing Stablecoin Shift Bank of America's move into digital currencies reflects a clear shift in the financial landscape—an uncertain but necessary step that no major bank can afford to ignore. While details are still being finalized and collaboration among competing banks will be crucial to building a stablecoin network, Bank of America's core business remains solid, consistently exceeding expectations. With its strong balance sheet and operational scale, the bank is well-positioned to lead innovation in this emerging space. One thing is sure: the GENIUS Act favors large institutions, and Bank of America is well placed to capitalize on it.
Globe and Mail
23 minutes ago
- Globe and Mail
Can Investing $10,000 in Quantum Computing (QUBT) Stock Turn Into $1 Million by 2035?
Quantum Computing (NASDAQ: QUBT) is an up-and-coming pioneer in the red-hot field of quantum computing. Could investing $10,000 in this stock turn into $1 million by 2035? It's possible, but the odds are stacked against it. That said, I think there is a viable path for Quantum Computing to make you a millionaire over the next 10 years. Here's what would be required. What would it take for Quantum Computing stock to turn $10,000 into $1 million by 2035? Quantum Computing's market cap currently hovers around $2.66 billion. Its share price was $18.88 at the market close on June 20, 2025. An investment of $10,000 would buy 529 shares at that price, with $12.48 left over. The company's share price would need to grow 100x to $1,888 for a $10,000 initial investment (assuming you didn't buy any fractional shares) to be worth $1 million in a decade. That reflects a compound annual growth rate (CAGR) of roughly 58.49%. Quantum Computing has certainly demonstrated that it can deliver a much greater annual return than that over the short term. Over the last 12 months, the stock has skyrocketed by more than 3,000%. Sustaining a CAGR of 58.49% over 10 years is a daunting task, but it's not impossible. For example, a $10,000 investment in Nvidia in 2015 would be worth over $2.6 million today. Of course, you would have had to resist the temptation to sell during the GPU stock's huge swings up and down during that period. How could it happen? Now for a more difficult question: How could Quantum Computing stock achieve a CAGR of 58.49% over the next 10 years? To answer this question, we need to understand the company's business. Quantum Computing uses integrated photonics (computing with particles of light) and nonlinear quantum optics to develop quantum computers. The company believes its approach to quantum computing is superior to rivals' methods that use superconducting, trapped-ion, and annealing architectures. Photons' advantages include lower energy consumption, faster processing, and scalability. The photonic integrated circuit market size in 2024 was around $15 billion. Over the next five years, this market is projected to expand by a CAGR of 20.5% to $38.4 billion. While that is an impressive growth rate, it isn't enough to propel Quantum Computing stock 100x higher. But Quantum Computing could grow significantly faster than the overall photonic integrated circuit market. The company's thin film lithium niobate wafers, which it believes will be "the silicon of the future," could make it possible. Also, the photonic integrated circuit market's growth could accelerate beyond 2029. I could envision this occurring if the adoption of the technology in areas such as artificial intelligence (AI), autonomous vehicles, and high-performance computing takes off in a huge way. Evaluating the odds It's quite possible that investing $10,000 in Quantum Computing stock could make you a millionaire over the next 10 years. But how probable is this scenario? The odds aren't great. For one thing, Quantum Computing's photonics technology might be surpassed by approaches that prove to be even better. Many of the companies investing heavily in developing quantum computers have deep pockets, including Google parent Alphabet, Amazon, IBM, Microsoft, and Nvidia. Other rising stars in the quantum computing industry, such as IonQ, D-Wave Quantum, and Rigetti Computing, could potentially be bigger winners than Quantum Computing. Perhaps progress in advancing quantum computing technology won't be fast enough to support the market growth required for Quantum Computing to be a millionaire-maker. I suspect that won't be the case, but I wouldn't rule it out. The good news for investors, though, is that Quantum Computing doesn't have to turn an initial $10,000 into $1 million by 2035 to still deliver exceptional returns. Should you invest $1,000 in Quantum Computing right now? Before you buy stock in Quantum Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Quantum Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Keith Speights has positions in Alphabet, Amazon, and Microsoft. The Motley Fool has positions in and recommends Alphabet, Amazon, International Business Machines, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Globe and Mail
an hour ago
- Globe and Mail
Berkshire Hathaway Is the Largest Financial Company by Market Cap. But Is It a Buy?
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is the largest financial company by market cap at more than $1 trillion, according to research from The Motley Fool. Its stock has been massively successful, rising nearly 170% over the past five years. But when longtime Berkshire Hathaway CEO and iconic investor Warren Buffett announced recently that he will step away from leading the company at the end of this year, some investors were left wondering if Berkshire is still worth buying without the Oracle of Omaha at the helm. While change can be scary, here's why Berkshire Hathaway stock is still worth buying. 1. The company is well-diversified The resilience of many companies is built on how well-diversified they are. This can come from product diversification or by catering to different types of customers, but the important part is for companies to be able to benefit from some parts of their business even while others are slowing down. Berkshire easily fits this description because the company is a conglomerate of more than 60 businesses, ranging from insurance companies (including GEICO) to energy businesses, industrial companies, and consumer goods makers. Of course, the company's huge stock portfolio of more than 30 stocks also adds to the financial diversification with its investments of nearly $279 billion. By spreading its ownership across so many different types of businesses and investing in a diverse field of stocks, investors can be sure that no matter what's happening with the broader economy or specific industries, Berkshire isn't overexposed to risk. 2. It has nearly $348 billion in cash There are multiple reasons why having such a large cash hoard is important. First, this cash pile means that if difficult economic times are around the corner, Berkshire will easily be able to weather the storm. It also opens up the opportunity for the company to buy other companies it sees as a good value, or buy stocks that it views as undervalued. What's more, Berkshire has been a longtime purchaser of its own stock. A large cash reserve means the company has enough money for continued share buybacks, which boost shareholder value. In short, Berkshire's $348 billion in cash and cash equivalents gives the company massive flexibility. If it needs to buy a distressed company at a discount price, it can. If it wants to boost its buybacks, it can do that as well. And if the market takes a downturn and stocks are on sale, then Berkshire can move quickly to expand its portfolio even further. 3. Its stock is relatively inexpensive You might assume that a company with a market cap of $1 trillion and share price gains of 170% over the past half-decade would be expensive. But Berkshire's price-to-earnings ratio is just 13 right now, far cheaper than the S&P 500 's average of about 28. This means you can buy Berkshire's shares at a relative discount to the broader market, despite the company's strong financial position and impressive share price gains in the recent past. There's hardly a better deal out there for a company that's massively profitable and well-diversified. But what about Buffett leaving? I understand the concern some potential Berkshire investors have with Buffett stepping away from the CEO role. But two things are important to note here. The first is that Buffett is stepping away because of his age -- he's 94 -- and not because of a failure in management. That's important to point out, because Buffett and his management have been able to plan for this transition, instead of being forced into a major change due to mismanagement. Second, and just as important, is the fact that because Berkshire is a conglomerate of businesses, little will change in the day-to-day operation of the more than 60 businesses in its portfolio. They all have their own CEOs and management teams and will continue to operate as usual once Buffett steps down at the end of this year. Longtime Berkshire executive Greg Abel will take over the CEO role, and many believe that he'll keep the company's focus on value businesses. With Abel inheriting a large stock portfolio, strong financial position, and well-diversified business, Berkshire is in a fantastic place to weather the transition well. Should you invest $1,000 in Berkshire Hathaway right now? Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
